[go: up one dir, main page]

GB1018125A - Chemical products - Google Patents

Chemical products

Info

Publication number
GB1018125A
GB1018125A GB8798/63A GB879863A GB1018125A GB 1018125 A GB1018125 A GB 1018125A GB 8798/63 A GB8798/63 A GB 8798/63A GB 879863 A GB879863 A GB 879863A GB 1018125 A GB1018125 A GB 1018125A
Authority
GB
United Kingdom
Prior art keywords
medicament
mixture
polymixin
isoproterenol
neomycin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB8798/63A
Inventor
John Dolan Mullins
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of GB1018125A publication Critical patent/GB1018125A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Otolaryngology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A self-propelling medicament composition comprises a suspension of a solid, substantially anhydrous medicament in a substantially anhydrous liquid carrier consisting essentially of a mixture of a non-toxic propellant having a vapour pressure of from 15 to 70 p.s.i.g. at 70 DEG F. and ethanol the medicament being substantially insoluble in the carrier and having a particle size from 0.5 to 10 microns and the ethanol being present in an amount of from 0.5% to 5% by weight of the composition. The medicament may be for example insulin, tri-iodothyronine or adrenaline; an anti-inflammatory steroid such as hydrocortisone, prednisolone or dexamethasone; an antibiotic such as penicillin neomycin polymixin, tetracycline, chlortetracycline or oxytetracycline; a broncho-dilator such as isoproterenol, phenisononone, epinephrine, phenylephrine or meterainol; an anti-nauseant such as cyclizine, meclizine, pipamazine, dimenhydrinate, or trimethobenzamide; an analgesic such as ergotamine; an antihistamine such as cyproheptadine; an antitussive such as noscapine, or mixtures thereof. Two examples are given of mixtures of dexamethasone and isoproterenol and one example of a mixture of neomycin and polymixin. The propellant may be a halogenated alkane or a mixture of such compounds.ALSO:A self propelling medicament composition comprises a suspension of a solid, substantially anhydrous medicament in a substantially anhydrous liquid carrier consisting essentially of a mixture of a non-toxic propellant having a vapour pressure of from 15 to 70p.s.i.g. at 70 DEG F and ethanol, the medicament being substantially insoluble in the carrier and having a particle size from 0.5 to 10 microns, and the ethanol being present in an amount of from 0.5% to 5% by weight of the composition. The medicament may be for example insulin, tri-iodothyronine or adrenaline; an anti-inflammatory steroid such as hydrocortisone, prednisolone or dexamethasone; an antibiotic such as penicillin, neomycin, polymixin, tetracycline, chlortetracycline or oxytetracycline; a broncho-dilator such as isoproterenol, phenisonone, epinephrine, phenylephrine or metaraminol; an anti-nauseant such as cyclizine, meclizine, pipamazine, dimenhydrinate, or trimethobenzamide; an analgesic such as ergotamine; an antihistamine such as cyproheptadine; an antitussive such as noscapine, or mixtures thereof. Two examples are given of mixtures of dexamethasone and isoproterenol and one example of a mixture of neomycin and polymixin. The propellant may be a halogenated alkane or a mixture of such compounds.
GB8798/63A 1962-11-29 1963-03-05 Chemical products Expired GB1018125A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US241022A US3219533A (en) 1962-11-29 1962-11-29 Aerosol solid medicament in propellant and low-level ethanol avoiding higher-level ethanol dispersed-solid reflocculation

Publications (1)

Publication Number Publication Date
GB1018125A true GB1018125A (en) 1966-01-26

Family

ID=22908922

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8798/63A Expired GB1018125A (en) 1962-11-29 1963-03-05 Chemical products

Country Status (5)

Country Link
US (1) US3219533A (en)
BE (1) BE629985A (en)
DE (1) DE1492015A1 (en)
GB (1) GB1018125A (en)
NL (1) NL289785A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2482457A1 (en) * 1980-05-19 1981-11-20 Orion Yhtymae Oy PROCESS FOR THE PREPARATION OF A MIXTURE OF ANTI-INFLAMMATORY STEROID AND A FLUOROCHLOROHYDROCARBIDE FOR USE AS A PROPELLING AGENT
EP0122036A1 (en) * 1983-03-09 1984-10-17 Teijin Limited Powdery pharmaceutical composition for nasal administration
FR2621817A1 (en) * 1987-10-19 1989-04-21 Medipro DRUG COMPRISING POLYMYXIN B, TOBRAMYCIN AND AMPHOTERICIN B VAPORIZED
FR2621818A1 (en) * 1987-10-19 1989-04-21 Medipro MEDICINE COMPRISING THE COMBINATION OF POLYMIXIN B, NETILMICIN AND AMPHOTERICIN B BY VAPORIZATION

Families Citing this family (146)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3482015A (en) * 1965-02-08 1969-12-02 Merck & Co Inc Aerosol composition of phenylephrine tartrate and the production of such
US3282791A (en) * 1965-08-17 1966-11-01 Merck & Co Inc Inhalation aerosol suspension of anhydrous disodium dexamethasone phosphate, propellents, and sorbitan trioleate
US3895111A (en) * 1973-06-27 1975-07-15 American Cyanamid Co Asthma treatment by inhalation of micronized N,N-diethyl-4-methyl-1-piperazinecarboxamide pamoate
GR78151B (en) * 1982-04-05 1984-09-26 Alcon Lab Inc
US4581225A (en) * 1984-04-25 1986-04-08 Eli Lilly And Company Sustained release intranasal formulation and method of use thereof
US5766573A (en) * 1988-12-06 1998-06-16 Riker Laboratories, Inc. Medicinal aerosol formulations
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
US5439670A (en) * 1989-11-28 1995-08-08 Riker Laboratories, Inc. Medicinal aerosol formulations
DE4003270A1 (en) * 1990-02-03 1991-08-08 Boehringer Ingelheim Kg NEW SPEED GASES AND THEIR USE IN MEDICINE PREPARATIONS
US5785952A (en) * 1990-11-09 1998-07-28 Glaxo Group Limited Aerosol medicament formulation having a surface coating of surfactant
US5919435A (en) * 1990-11-09 1999-07-06 Glaxo Group Limited Aerosol formulation containing a particulate medicament
US5916540A (en) * 1994-10-24 1999-06-29 Glaxo Group Limited Aerosol formulations containing P134A and/or P227 and particulate medicament
US5674471A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Aerosol formulations containing P134a and salbutamol
US5744123A (en) * 1991-12-12 1998-04-28 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
US5736124A (en) * 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
NZ246046A (en) * 1991-12-12 1995-12-21 Glaxo Group Ltd Aerosol comprising a particulate medicament in a fluorocarbon or chlorofluorohydrocarbon and a polar cosolvent
US5653962A (en) * 1991-12-12 1997-08-05 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
CA2421976C (en) * 1991-12-12 2004-04-20 Glaxo Group Limited Medicaments
US5658549A (en) * 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
EP0717987B1 (en) * 1991-12-18 2001-08-29 Minnesota Mining And Manufacturing Company Suspension aerosol formulations
US7105152B1 (en) 1991-12-18 2006-09-12 3M Innovative Properties Company Suspension aerosol formulations
US5603918A (en) * 1995-06-09 1997-02-18 Boehringer Ingelheim Pharmaceuticals, Inc. Aerosol composition of a salt of ipratropium and a salt of albuterol
US8022095B2 (en) * 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
US7899511B2 (en) 2004-07-13 2011-03-01 Dexcom, Inc. Low oxygen in vivo analyte sensor
US7657297B2 (en) 2004-05-03 2010-02-02 Dexcom, Inc. Implantable analyte sensor
US9155496B2 (en) 1997-03-04 2015-10-13 Dexcom, Inc. Low oxygen in vivo analyte sensor
US8974386B2 (en) 1998-04-30 2015-03-10 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US6175752B1 (en) * 1998-04-30 2001-01-16 Therasense, Inc. Analyte monitoring device and methods of use
US8465425B2 (en) 1998-04-30 2013-06-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8346337B2 (en) 1998-04-30 2013-01-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8480580B2 (en) 1998-04-30 2013-07-09 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US20080076997A1 (en) * 1998-04-30 2008-03-27 Abbott Diabetes Care, Inc. Analyte monitoring device and methods of use
US6949816B2 (en) 2003-04-21 2005-09-27 Motorola, Inc. Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same
US9066695B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8688188B2 (en) 1998-04-30 2014-04-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US7521068B2 (en) * 1998-11-12 2009-04-21 Elan Pharma International Ltd. Dry powder aerosols of nanoparticulate drugs
WO2001019342A2 (en) * 1999-09-11 2001-03-22 Glaxo Group Limited Pharmaceutical formulation of fluticasone propionate
US6458387B1 (en) * 1999-10-18 2002-10-01 Epic Therapeutics, Inc. Sustained release microspheres
US20050048001A1 (en) * 1999-11-23 2005-03-03 Cripps Alan Leslie Pharmaceutical formulations of salmeterol
WO2001047493A1 (en) * 1999-12-24 2001-07-05 Glaxo Group Limited Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate
DE10043509A1 (en) * 2000-09-01 2002-03-14 Asta Medica Ag Solid peptide preparations for inhalation and their manufacture
DE60138641D1 (en) 2000-10-27 2009-06-18 Baxter Healthcare Sa PREPARATION OF MICRO BEADS
US6560471B1 (en) 2001-01-02 2003-05-06 Therasense, Inc. Analyte monitoring device and methods of use
US7041468B2 (en) 2001-04-02 2006-05-09 Therasense, Inc. Blood glucose tracking apparatus and methods
DE60227659D1 (en) * 2001-05-24 2008-08-28 Alexza Pharmaceuticals Inc ADMINISTRATION OF ANTIHISTAMINICA BY INHALATION
US7090830B2 (en) 2001-05-24 2006-08-15 Alexza Pharmaceuticals, Inc. Drug condensation aerosols and kits
CA2447519C (en) * 2001-05-24 2008-09-16 Alexza Molecular Delivery Corporation Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route
US7498019B2 (en) 2001-05-24 2009-03-03 Alexza Pharmaceuticals, Inc. Delivery of compounds for the treatment of headache through an inhalation route
US7645442B2 (en) 2001-05-24 2010-01-12 Alexza Pharmaceuticals, Inc. Rapid-heating drug delivery article and method of use
US7585493B2 (en) 2001-05-24 2009-09-08 Alexza Pharmaceuticals, Inc. Thin-film drug delivery article and method of use
US7766013B2 (en) 2001-06-05 2010-08-03 Alexza Pharmaceuticals, Inc. Aerosol generating method and device
CA2446904A1 (en) * 2001-05-24 2003-04-03 Alexza Molecular Delivery Corporation Delivery of drug esters through an inhalation route
WO2002094242A1 (en) * 2001-05-24 2002-11-28 Alexza Molecular Delivery Corporation Delivery of rizatriptan or zolmitriptan through an inhalation route
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US7458374B2 (en) 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
US20030035774A1 (en) * 2001-07-18 2003-02-20 Adjei Akwete L. Salt/ion pair medicinal aerosol formulation
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
EP1944016A1 (en) 2001-08-16 2008-07-16 Baxter International Inc. Propellant-based microparticle formulatons
DE60226613D1 (en) * 2001-08-16 2008-06-26 Baxter Int PHARMACEUTICAL FORMS CONTAINING MICROPARTICLES AND GAS
WO2003041693A1 (en) * 2001-11-09 2003-05-22 Alexza Molecular Delivery Corporation Delivery of diazepam through an inhalation route
US9282925B2 (en) 2002-02-12 2016-03-15 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US9247901B2 (en) 2003-08-22 2016-02-02 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8010174B2 (en) 2003-08-22 2011-08-30 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8858434B2 (en) 2004-07-13 2014-10-14 Dexcom, Inc. Transcutaneous analyte sensor
US8260393B2 (en) 2003-07-25 2012-09-04 Dexcom, Inc. Systems and methods for replacing signal data artifacts in a glucose sensor data stream
DE60309300T3 (en) * 2002-03-20 2011-02-24 Elan Pharma International Ltd. NANOPARTICLE COMPOSITIONS OF ANGIOGENIC INHIBITORS
US7582284B2 (en) 2002-04-17 2009-09-01 Nektar Therapeutics Particulate materials
WO2003094900A1 (en) 2002-05-13 2003-11-20 Alexza Molecular Delivery Corporation Delivery of drug amines through an inhalation route
US7550133B2 (en) 2002-11-26 2009-06-23 Alexza Pharmaceuticals, Inc. Respiratory drug condensation aerosols and methods of making and using them
PT1567164E (en) 2002-11-26 2009-03-31 Alexza Pharmaceuticals Inc Use of loxapine for the manufacture of a medicament for the treatment of pain
US20040105818A1 (en) 2002-11-26 2004-06-03 Alexza Molecular Delivery Corporation Diuretic aerosols and methods of making and using them
US7913688B2 (en) 2002-11-27 2011-03-29 Alexza Pharmaceuticals, Inc. Inhalation device for producing a drug aerosol
JP2007516404A (en) 2003-05-21 2007-06-21 アレックザ ファーマシューティカルズ, インコーポレイテッド Optically or electrically ignited built-in heating unit and drug supply unit using the same
US7761130B2 (en) 2003-07-25 2010-07-20 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US8423113B2 (en) 2003-07-25 2013-04-16 Dexcom, Inc. Systems and methods for processing sensor data
US7774145B2 (en) 2003-08-01 2010-08-10 Dexcom, Inc. Transcutaneous analyte sensor
US8160669B2 (en) 2003-08-01 2012-04-17 Dexcom, Inc. Transcutaneous analyte sensor
US6931327B2 (en) 2003-08-01 2005-08-16 Dexcom, Inc. System and methods for processing analyte sensor data
US8369919B2 (en) 2003-08-01 2013-02-05 Dexcom, Inc. Systems and methods for processing sensor data
US8886273B2 (en) 2003-08-01 2014-11-11 Dexcom, Inc. Analyte sensor
US8845536B2 (en) 2003-08-01 2014-09-30 Dexcom, Inc. Transcutaneous analyte sensor
US7519408B2 (en) 2003-11-19 2009-04-14 Dexcom, Inc. Integrated receiver for continuous analyte sensor
US7591801B2 (en) 2004-02-26 2009-09-22 Dexcom, Inc. Integrated delivery device for continuous glucose sensor
US7494465B2 (en) 2004-07-13 2009-02-24 Dexcom, Inc. Transcutaneous analyte sensor
US8761856B2 (en) 2003-08-01 2014-06-24 Dexcom, Inc. System and methods for processing analyte sensor data
US8275437B2 (en) 2003-08-01 2012-09-25 Dexcom, Inc. Transcutaneous analyte sensor
US20190357827A1 (en) 2003-08-01 2019-11-28 Dexcom, Inc. Analyte sensor
US8622905B2 (en) 2003-08-01 2014-01-07 Dexcom, Inc. System and methods for processing analyte sensor data
US9135402B2 (en) 2007-12-17 2015-09-15 Dexcom, Inc. Systems and methods for processing sensor data
US7955261B2 (en) 2003-08-01 2011-06-07 Dexcom, Inc. System and methods for processing analyte sensor data
US20140121989A1 (en) 2003-08-22 2014-05-01 Dexcom, Inc. Systems and methods for processing analyte sensor data
US7920906B2 (en) 2005-03-10 2011-04-05 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US9247900B2 (en) 2004-07-13 2016-02-02 Dexcom, Inc. Analyte sensor
US8423114B2 (en) 2006-10-04 2013-04-16 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US11633133B2 (en) 2003-12-05 2023-04-25 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US8364231B2 (en) 2006-10-04 2013-01-29 Dexcom, Inc. Analyte sensor
US8287453B2 (en) 2003-12-05 2012-10-16 Dexcom, Inc. Analyte sensor
US8774886B2 (en) 2006-10-04 2014-07-08 Dexcom, Inc. Analyte sensor
ATE480761T1 (en) 2003-12-05 2010-09-15 Dexcom Inc CALIBRATION METHODS FOR A CONTINUOUSLY WORKING ANALYTICAL SENSOR
EP3263032B1 (en) 2003-12-09 2024-01-24 Dexcom, Inc. Signal processing for continuous analyte sensor
WO2005065649A1 (en) * 2003-12-31 2005-07-21 Cydex, Inc. Inhalant formulation containing sulfoalkyl ether ϝ-cyclodextrin and corticosteroid
US20070020196A1 (en) * 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid prepared from a unit dose suspension
US20070020299A1 (en) * 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
US7637868B2 (en) 2004-01-12 2009-12-29 Dexcom, Inc. Composite material for implantable device
US8808228B2 (en) 2004-02-26 2014-08-19 Dexcom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
US8792955B2 (en) 2004-05-03 2014-07-29 Dexcom, Inc. Transcutaneous analyte sensor
US7540286B2 (en) 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
US20070045902A1 (en) 2004-07-13 2007-03-01 Brauker James H Analyte sensor
US8565848B2 (en) 2004-07-13 2013-10-22 Dexcom, Inc. Transcutaneous analyte sensor
US7640048B2 (en) 2004-07-13 2009-12-29 Dexcom, Inc. Analyte sensor
US7783333B2 (en) 2004-07-13 2010-08-24 Dexcom, Inc. Transcutaneous medical device with variable stiffness
US8452368B2 (en) 2004-07-13 2013-05-28 Dexcom, Inc. Transcutaneous analyte sensor
EP2246086A3 (en) 2004-08-12 2012-11-21 Alexza Pharmaceuticals, Inc. Aerosol drug delivery device incorporating percussively activated heating unit
US20090076360A1 (en) 2007-09-13 2009-03-19 Dexcom, Inc. Transcutaneous analyte sensor
US8133178B2 (en) 2006-02-22 2012-03-13 Dexcom, Inc. Analyte sensor
US8367734B1 (en) 2005-08-11 2013-02-05 Amphastar Pharmaceuticals Inc. Stable epinephrine suspension formulation with high inhalation delivery efficiency
US20070178049A1 (en) * 2005-12-20 2007-08-02 Verus Pharmaceuticals, Inc. Systems and methods for the delivery of corticosteroids having an enhanced pharmacokinetic profile
US20070197486A1 (en) * 2005-12-20 2007-08-23 Verus Pharmaceuticals, Inc. Methods and systems for the delivery of corticosteroids
US20070185066A1 (en) * 2005-12-20 2007-08-09 Verus Pharmaceuticals, Inc. Systems and methods for the delivery of corticosteroids
US20070160542A1 (en) * 2005-12-20 2007-07-12 Verus Pharmaceuticals, Inc. Methods and systems for the delivery of corticosteroids having an enhanced pharmacokinetic profile
US20070197487A1 (en) * 2005-12-20 2007-08-23 Verus Pharmaceuticals, Inc. Systems and methods for the delivery of corticosteroids having an increased lung deposition
US20070249572A1 (en) * 2005-12-20 2007-10-25 Verus Pharmaceuticals, Inc. Systems and methods for the delivery of corticosteroids
US20070178050A1 (en) * 2005-12-20 2007-08-02 Verus Pharmaceuticals, Inc. Methods and systems for the delivery of corticosteroids having an increased lung depositon
US9757061B2 (en) 2006-01-17 2017-09-12 Dexcom, Inc. Low oxygen in vivo analyte sensor
EP1991110B1 (en) 2006-03-09 2018-11-07 DexCom, Inc. Systems and methods for processing analyte sensor data
US20080071157A1 (en) 2006-06-07 2008-03-20 Abbott Diabetes Care, Inc. Analyte monitoring system and method
US20070286814A1 (en) * 2006-06-12 2007-12-13 Medispray Laboratories Pvt. Ltd. Stable aerosol pharmaceutical formulations
ES2538082T3 (en) 2007-02-11 2015-06-17 Map Pharmaceuticals Inc Therapeutic administration method of DHE to allow rapid migraine relief while minimizing the side effects profile
EP2121088B1 (en) 2007-03-09 2016-07-13 Alexza Pharmaceuticals, Inc. Heating unit for use in a drug delivery device
US8562558B2 (en) 2007-06-08 2013-10-22 Dexcom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
US12370352B2 (en) 2007-06-28 2025-07-29 Cydex Pharmaceuticals, Inc. Nasal and ophthalmic delivery of aqueous corticosteroid solutions
EP4098177A1 (en) 2007-10-09 2022-12-07 DexCom, Inc. Integrated insulin delivery system with continuous glucose sensor
WO2009088553A1 (en) * 2007-10-22 2009-07-16 Board Of Regents, The University Of Texas System Dry powder drug delivery formulations, methods of use, and devices therefore
US8417312B2 (en) 2007-10-25 2013-04-09 Dexcom, Inc. Systems and methods for processing sensor data
US8054177B2 (en) * 2007-12-04 2011-11-08 Avaya Inc. Systems and methods for facilitating a first response mission at an incident scene using patient monitoring
US9839395B2 (en) 2007-12-17 2017-12-12 Dexcom, Inc. Systems and methods for processing sensor data
US9143569B2 (en) 2008-02-21 2015-09-22 Dexcom, Inc. Systems and methods for processing, transmitting and displaying sensor data
US8396528B2 (en) 2008-03-25 2013-03-12 Dexcom, Inc. Analyte sensor
EP4549933A3 (en) 2008-09-19 2025-05-21 DexCom, Inc. Particle-containing membrane and particulate electrode for analyte sensors
EP2410910A4 (en) 2009-03-27 2014-10-15 Dexcom Inc Methods and systems for promoting glucose management
EP2697650B1 (en) 2011-04-15 2020-09-30 Dexcom, Inc. Advanced analyte sensor calibration and error detection
CN212438615U (en) 2017-10-24 2021-02-02 德克斯康公司 Wearable device
US11331022B2 (en) 2017-10-24 2022-05-17 Dexcom, Inc. Pre-connected analyte sensors
KR102852740B1 (en) 2018-02-02 2025-08-29 알렉스자 파마스티칼즈, 인크. Electrical Condensation Aerosol Device

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2801201A (en) * 1953-04-09 1957-07-30 Lincoln Lab Inc Burn treatment filling for pressure packaged dispenser
US2798835A (en) * 1954-01-18 1957-07-09 American Cyanamid Co Newcastle disease and infectious bronchitis vaccines and production thereof
US2798836A (en) * 1954-01-18 1957-07-09 American Cyanamid Co Inhalable live virus veterinary vaccine
US2959325A (en) * 1954-04-29 1960-11-08 Risdon Mfg Co Method and apparatus for dispensing dry powders
US2802772A (en) * 1954-09-09 1957-08-13 Merck & Co Inc Aerosols compositions; bomb, and process for treating flocks of chickens
US2782975A (en) * 1955-04-20 1957-02-26 American Cyanamid Co Sprayable amorphous antibiotic composition, pressurized container with same, and method of preparing
BE556587A (en) * 1957-01-31 1957-04-11
US2987439A (en) * 1958-01-07 1961-06-06 William Cooper & Nephews Inc Method of applying an aerosol to the eye
US3073743A (en) * 1959-07-30 1963-01-15 Upjohn Co Antiinflammatory steroid acetonide compositions and therapy
NL125158C (en) * 1959-10-01
NL262354A (en) * 1960-03-17

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2482457A1 (en) * 1980-05-19 1981-11-20 Orion Yhtymae Oy PROCESS FOR THE PREPARATION OF A MIXTURE OF ANTI-INFLAMMATORY STEROID AND A FLUOROCHLOROHYDROCARBIDE FOR USE AS A PROPELLING AGENT
DE3119745A1 (en) * 1980-05-19 1982-02-11 Orion-yhtymä Oy, 00101 Helsinki METHOD FOR PRODUCING A MIXTURE OF AN ANTI-INFLAMMATORY STEROID AND A FLUOROCHLORINE HYDROCARBON USED AS A PROPELLANT
EP0122036A1 (en) * 1983-03-09 1984-10-17 Teijin Limited Powdery pharmaceutical composition for nasal administration
FR2621817A1 (en) * 1987-10-19 1989-04-21 Medipro DRUG COMPRISING POLYMYXIN B, TOBRAMYCIN AND AMPHOTERICIN B VAPORIZED
FR2621818A1 (en) * 1987-10-19 1989-04-21 Medipro MEDICINE COMPRISING THE COMBINATION OF POLYMIXIN B, NETILMICIN AND AMPHOTERICIN B BY VAPORIZATION
WO1989003673A1 (en) * 1987-10-19 1989-05-05 Medipro Drug comprising the association of polymyxin b, tobramycin and amphotericin b administered by spraying
WO1989003672A1 (en) * 1987-10-19 1989-05-05 Medipro Drug comprising the association of polymyxin b, netilmycin and amphotericin b, administered by spraying

Also Published As

Publication number Publication date
BE629985A (en)
DE1492015A1 (en) 1969-03-06
US3219533A (en) 1965-11-23
NL289785A (en)

Similar Documents

Publication Publication Date Title
GB1018125A (en) Chemical products
US3169095A (en) Self-propelling powder-dispensing compositions
ES413911A1 (en) Chemical compounds
JPS5225013A (en) Insulin pharmaceutical for nasal administration
EP0165696A3 (en) Improved transdermal dosage form
HU173465B (en) Process for preparing thieno-benzoxepine-acetic acid derivatives and pharmaceutical preparations containing these compounds as active substances
AU8203875A (en) Process for the manufacture of insulin, analogs and de- rivatives thereof
JPS57109721A (en) Carcinostatic agent
JPS52108028A (en) Remedies for dysacousis
GB1488995A (en) Compositions containing anti-androgenic compounds
GB1016959A (en) Substituted steroid hormones
AU461405B2 (en) Protected decapepride derivatives of gonadotropin releasing hormone
GB1089043A (en) Aerosol compositions containing phenylephrine derivatives
HU171352B (en) Process for preparing derivatives of the beta-naphtyl-methyl-piperazine and pharmaceutical preparations containing such compounds
IL39889A0 (en) Inhalant compositions containing an anticholinergically active compound,and inhalers for the administration thereof
JPS523006A (en) Process for stabilization of furon
GB1255805A (en) Improvements in delayed release pharmaceutical preparations and stabilisation of vitamins
GB1174617A (en) A Method of Preparing a D-6-Methyl-8-Aminoisoergolene Derivative
JPS5226752A (en) Particle medicine ejector
GB1187101A (en) New 14alpha-Hydroxy Steroids and process for their manufacture
GB1109964A (en) Complex of theophylline and soluble saccharin, process for its preparation and therapeutic composition comprising same
GB974989A (en) Hydroxy-benzenesulphonyl-ureas and preparations containing them
GB864615A (en) 4-chloro-testosterone-17ª‰-acetate
GB946547A (en) Veterinary preparations for combating endoparasites by intravenous injection
CA776679A (en) Urazole compounds, pharmaceutical compositions containing same, and process of administering same